- Home
- GROV vs XGN Comparison
GROV vs XGN Comparison
Compare GROV & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- XGN
- Stock Information
- Founded
- GROV 2016
- XGN 2002
- Country
- GROV United States
- XGN United States
- Employees
- GROV N/A
- XGN N/A
- Industry
- GROV Package Goods/Cosmetics
- XGN Medical Specialities
- Sector
- GROV Consumer Discretionary
- XGN Health Care
- Exchange
- GROV Nasdaq
- XGN Nasdaq
- Market Cap
- GROV 59.0M
- XGN 72.3M
- IPO Year
- GROV N/A
- XGN 2019
- Fundamental
- Price
- GROV $1.40
- XGN $5.15
- Analyst Decision
- GROV Buy
- XGN Buy
- Analyst Count
- GROV 1
- XGN 1
- Target Price
- GROV $2.00
- XGN $7.00
- AVG Volume (30 Days)
- GROV 159.2K
- XGN 164.8K
- Earning Date
- GROV 11-12-2024
- XGN 11-12-2024
- Dividend Yield
- GROV N/A
- XGN N/A
- EPS Growth
- GROV N/A
- XGN N/A
- EPS
- GROV N/A
- XGN N/A
- Revenue
- GROV $213,781,000.00
- XGN $55,751,000.00
- Revenue This Year
- GROV N/A
- XGN $6.74
- Revenue Next Year
- GROV $0.84
- XGN $17.32
- P/E Ratio
- GROV N/A
- XGN N/A
- Revenue Growth
- GROV N/A
- XGN 8.00
- 52 Week Low
- GROV $1.19
- XGN $1.30
- 52 Week High
- GROV $2.44
- XGN $6.22
- Technical
- Relative Strength Index (RSI)
- GROV 47.22
- XGN 58.53
- Support Level
- GROV $1.30
- XGN $4.71
- Resistance Level
- GROV $1.56
- XGN $6.22
- Average True Range (ATR)
- GROV 0.08
- XGN 0.55
- MACD
- GROV -0.02
- XGN -0.02
- Stochastic Oscillator
- GROV 37.88
- XGN 46.23
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.